Clinical Trials Logo

Anxiety State clinical trials

View clinical trials related to Anxiety State.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03227562 Terminated - Anxiety State Clinical Trials

Is Initial Response to Low Dose Risperidone Predictive for Outcome in Anxiety?

Start date: September 1, 2017
Phase: Phase 3
Study type: Interventional

Risperidone at low dosage is often used as treatment of acute anxiety symptom. However, patients may be either responder or not. Here we hypothesized that the early response to a low dose of risperidone is predictive to risperidone efficiency. Subjects with acute anxiety symptoms (Hospital anxiety depression scale) and risperidone prescription would be proposed to be enrolled in the study. A check-up is made at D0, then the subjects begin the treatment (0.5mg risperidone). The same check-up is carried out on the following day (D1). The subjects fulfil a last check-up 12 week after the beginning of treatment (W12). During the D1-W12, the psychiatrist may changes the treatment.